David J. Goldstein, MD, PhD
- 4Articles
- 14.6KReads
- 2002–2003Active
- 10Collaborators
- 45Citations
About
David J. Goldstein, MD, PhD, has published research focused on the treatment of major depressive disorder (MDD), particularly examining the use of duloxetine. His work includes clinical trials assessing duloxetine's efficacy and safety for both emotional and physical symptoms of depression. Goldstein's publications also address the role of primary care in managing depression.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
